1. Home
  2. TLIH vs ERNA Comparison

TLIH vs ERNA Comparison

Compare TLIH & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TLIH

Ten-League International Holdings Limited Ordinary Shares

N/A

Current Price

$0.49

Market Cap

11.8M

Sector

N/A

ML Signal

N/A

Logo Eterna Therapeutics Inc.

ERNA

Eterna Therapeutics Inc.

HOLD

Current Price

$1.19

Market Cap

10.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLIH
ERNA
Founded
1998
2018
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
10.0M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
TLIH
ERNA
Price
$0.49
$1.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
82.2K
187.4K
Earning Date
09-30-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$51,204,304.00
$1,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$1.08
52 Week High
$7.00
$11.07

Technical Indicators

Market Signals
Indicator
TLIH
ERNA
Relative Strength Index (RSI) N/A 45.72
Support Level N/A $1.15
Resistance Level N/A $1.29
Average True Range (ATR) 0.00 0.12
MACD 0.00 0.00
Stochastic Oscillator 0.00 40.63

Price Performance

Historical Comparison
TLIH
ERNA

About TLIH Ten-League International Holdings Limited Ordinary Shares

Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental and provision of engineering consultancy services to port, construction, civil engineering and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment and port machinery. The company operates in Singapore and Other International Countries.

About ERNA Eterna Therapeutics Inc.

Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.

Share on Social Networks: